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Corneal endothelial cells (CECs) are essential for maintaining corneal stromal hydration and ensuring its
transparency, which is necessary for normal vision. Dysfunction of CECs leads to stromal decompensa-
tion, loss of transparency and corneal blindness. Corneal endothelium has low proliferative potential
compared to surface epithelial cells leading to poor regeneration of CEC following injury. Additionally,
the tissue exhibits age related decline in endothelial cell density with re-organisation of the cell layer, but
no regeneration. The mechanisms which control proliferation and differentiation of neural crest derived
CEC progenitors are yet to be clearly elucidated.
Prdm (Positive regulatory domain) family of transcriptional regulators and chromatin modiﬁers are
important for driving differentiation of a variety of cellular types. Many Prdm proteins are expressed in
speciﬁc precursor cell populations and are necessary for their progression to a fully differentiated
phenotype. In the present work, we sought to identify members of the Prdm gene family which are
speciﬁcally expressed in human (h) CECs with a view to begin addressing their potential roles in CEC
biology, focussing especially on Prdm 4 and 5 genes. By performing semi-quantitative reverse tran-
scription coupled to PCR ampliﬁcation we found that in addition to Prdm4 and Prdm5, Prdm2 and Prdm10
genes are expressed in hCECs. We further found that cultured primary hCECs or immortalised HCEC-
12 cells express all of the Prdm genes found in CECs, but also express additional Prdm transcripts. This
difference is most pronounced between Prdm gene expression patterns of CECs isolated from healthy
human corneas and immortalised HCEC-12 cells. We further investigated Prdm 4 and Prdm 5 protein
expression in cultured primary hCECs and HCEC-12 cells as well as in a human cadaveric whole cornea.
Both Prdm 4 and Prdm 5 are expressed in human corneal endothelium, primary hCECs and in HCECs-
12 cells, characterised by expression of the Naþ/Kþ-ATPase. We observed that both proteins exhibit
cytosolic (intracellular, but non-nuclear and distinct from extracellular ﬂuid) as well as nuclear local-
isation within the endothelial layer, with Prdm 5 being more concentrated in the nuclei of the endo-
thelial cells than Prdm 4. Thus, our work identiﬁes novel Prdm genes speciﬁcally expressed in corneal
endothelial cells which may be important in the control of CEC differentiation and proliferation.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).rdm, Positive regulatory domain; SET, suppressor of variegation 3e9, enhancer of zeste, trithorax; DAB, 3,3'-
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Corneal endothelial cells (CECs) form a monolayer of highly
specialised cells found at the most posterior part of the cornea,
which maintain the stroma at the normal physiological level of
hydration at ca 78%. Loss of the endothelial cells leads to the
swelling of cornea and loss of corneal transparency (Eghrari et al.,
2015; Parekh et al., 2016). Currently, the treatment of such
decompensated corneas relies on human cadaveric corneal donor
transplantation with associated problems of immune rejection and
lack of immediate availability of donor tissue (Parekh et al., 2016).
Therefore, understanding the mechanisms which control hCEC
proliferation and differentiation from their precursors or from stem
cells/induced pluripotent stem cells (iPSCs) via re-programming is
highly desirable in order to begin developing rational strategies for
generating hCECs for therapeutic purpose.
Prdm proteins are a family of structurally related transcriptional
regulators, characterised by the presence of at least two distinct
domains, the zinc ﬁngers and the PR/SET (named after the
Drosophila transcription factors Suppressor of variegation 3e9,
Enhancer of Zeste and Trithorax (SET) and Positive regulatory
domain I-binding factor 1/Retinoblastoma protein-interacting zinc
ﬁnger gene 1 (PR) motifs originally identiﬁed in Prdm1 and Prdm2,
respectively) domains, similar to, but distinct from the SET domains
of histone lysine methyltransferases (Fog et al., 2012; Hohenauer
and Moore, 2012). Many of the Prdm proteins are instrumental in
controlling differentiation of a variety of cell types (Fog et al., 2012;
Hohenauer and Moore, 2012; Di Zazzo et al., 2013; Zannino and
Sagerstr€om, 2015). For example, Prdm 1 is involved in the speciﬁ-
cation of primordial germ cells, forelimb patterning, and reprog-
ramming of intestinal enterocytes (Ohinata et al., 2005; Bikoff et al.,
2009; Harper et al., 2011). Prdm 16 controls brown fat cell identity
as well as haematopoiesis and cardiac development (Zhang et al.,
2011; Chi and Cohen, 2016). Prdm 8 is required for rod bipolar
and type 2 OFF-cone bipolar cell survival and amacrine subtype
identity and its absence resembles the incomplete form of human
congenital stationary night blindness (CSNB) (Jung et al., 2015).
Importantly, Prdm 5 regulates expression of extracellular matrix
components and mutations in Prdm 5 gene lead to the brittle
cornea syndrome (BCS) (Burkitt Wright et al., 2011; Aldahmesh
et al., 2012; Micheal et al., 2016a). Prdm 5 is the only Prdm pro-
tein with a well-documented and characterised physiological role
in corneal cell biology. Intriguingly, Prdm 4 appears to control some
aspects of corneal biology as evidenced by the initial characteri-
sation of the mutant mice where Prdm 4 gene is deleted, which
show abnormalities in corneal morphology, thus making it a
potentially novel candidate gene that may be useful for therapeutic
purposes (MRC Harwell web reference).
Given the importance of Prdm proteins in controlling cell fate
decisions during development, we reasoned that some of them
may regulate various aspects of CEC proliferation and differentia-
tion. To date, no systematic analysis of expression of these genes in
corneal endothelial cells has been undertaken. Here, we present the
ﬁrst analysis of expression of all human Prdm genes in hCECs and
whole cadaveric cornea with special focus on the expression of
Prdm 4 and 5 genes because of their documented involvement in
corneal function. Further, we investigate the expression of Prdm
genes in cultured primary hCECs and an immortalised cell line,
HCEC-12 and ﬁnd that both show overlapping, but distinct
expression of Prdm genes as compared to CECs or the whole human
cornea. Isolated Descemet's membranes together with the attached
CECs express Prdm 2, 4, 5, 10 and very weakly Prdm 11 mRNA.
Within the whole cornea, we detected Prdm 1, 2, 4, 5 and 10mRNA
expression. Moreover, we demonstrate that two of the selected
Prdm proteins, Prdm 4 and Prdm 5, are expressed in both primaryhCECs and HCEC-12 cells. Both Prdm 4 and 5 are found in the
endothelial cells of the whole cornea. Our results pave the way for
further investigations into the roles of these Prdm genes in CEC
proliferation, maintenance and differentiationwhich may be useful
for generating CECs for cell transplantation.
2. Material and methods
2.1. RNA extraction and Reverse transcription-PCR (RT-PCR)
analysis of Prdm gene expression
RNA was extracted from whole human donor corneas, Desce-
met's membrane (DM)/Endothelium complex, primary cultured
human corneal endothelial cells (hCECs) and from cultured HCEC-
12 cells. To isolate total RNA from the normal cornea, Trizol® re-
agent (Invitrogen/ThermoFisher Scientiﬁc) was used according to
manufacturer's instructions. Human donor corneas were obtained
from Bristol and Manchester Eye Banks, UK, with research consent.
To isolate total RNA from the DM/Endothelium complex, hCEC and
HCEC-12 cells, we used micro-prep RNA extraction kit from Agilent
Technologies. A total of 5  105 HCEC-12 and primary hCECs were
harvested at passage six and two, respectively, following seven days
of culturing, for RNA extraction.
SuperScript® II Reverse Transcriptase was used to perform RT
according to themanufacturer's instructions using 1 mg of total RNA
and random hexamer primer mix (Invitrogen/ThermoFisher Sci-
entiﬁc). Subsequently, 1 ml of cDNA was used for PCR ampliﬁcation
with gene-speciﬁc primers. Control reactions were performed
without the addition of reverse transcriptase in the reaction mix.
Cycling for PCR ampliﬁcation was performed using the following
programme: 94 C for 2 min followed by 40 cycles of 94 C for 30 s,
59 C for 30 s, 72 C for 30 s, and a ﬁnal extension step at 72 C for
5 min. PCR products were separated using 2% agarose gel
electrophoresis.
The following gene-speciﬁc primers were used: Prdm1F 50
CAGTTCCTAAGAACGCCAACAGG 3’; Prdm1R 50 GTGCTGGATTCACA-
TAGCGCATC 3’; Prdm2F 50 TTGGGCTTGCTCAGGAGAAGAG 3’; Prdm-
2R 50 GCTGCTATCTCAGGGTTGTCTTC 3’; Prdm3(MDS)F 50 CCTTA-
TGTGGGAGAGCAGAGGT 3’; Prdm3(MDS)R 50 GAAGGCTATTCC-
TACGTCTGAGC 3’; Prdm3(MECOM)F 50 CCTGCTTCAGATGGTT-
CCTTGC 3’; Prdm3(MECOM)R 50 GGTGAAACAAGAATCCTGGAGAAG
3’; Prdm4F 50 CCAAAGCAGCTTGTTCTCCGTC 3’; Prdm4R 50 TAGAG-
GTCCAAAGCAAGTCCGC 3’; Prdm5F 50 ACTCTGAGGAGAGACC-
GTTCCA 3’; Prdm5R 50 AGCATCGCAGTGATGGCACTTG 3’; Prdm6F 50
GTGAGGAACACGCAGCATCTCT 3’; Prdm6R 50 TTCTCCGCAGTGCCTT-
GCACAT 3’; Prdm7F 50 AGACGAAGAGGCAGCCAACAGT 3’; Prdm7R
50 GCCACCAGGTTCTGCTCTTCAT 3’; Prdm8F 50 CTGTGTCCTGAGC-
CATACTTCC 3’; Prdm8R 50 CCTTCTGAGGAACCATTTGCTGC 3’;
Prdm9F 50 ACGAAGAGGCAGCCAACAATGG 3’; Prdm9R 50 GCCAC-
CAGGTTCTGCTCTTCAT 3’; Prdm10F 50 CCGCAAAGACTTCCTGTG-
TTCC 3’; Prdm10R 50 GCTGATGCGGTCGGCTTTCTTG 3’; Prdm11F 50
CCAGGAAACCATTCACCGCAAC 3’; Prdm11R 50 CCTCAGGTCTT-
CTGGGTTATCC 3’; Prdm12F 50 TGCACGTAACGAACAGGAGCAG 3’;
Prdm12R 50 GTGAGTTTCCGTACCACACCAG 3’; Prdm13F 50
CTAACTCCTTGGCTCAGTGGTTC 3’; Prdm13R 50 CAGTACCAGCA-
GATGTAGCGCT 3’; Prdm14F 50 CCTTGTGTGGTATGGAGACTGC 3’;
Prdm14R 50 CTTTCACATCTGTAGCCTTCTGC 3’; Prdm15F 50
GGCACTTGTGAGAAGACCTTCC 3’; Prdm15R 50 GAGGTTGCT-
GTTGGTGGAGAAG 3’; Prdm16F 50 CAGCCAATCTCACCAGACACCT 3’;
Prdm16R 50 GTGGCACTTGAAAGGCTTCTCC 3’.
2.2. Primary and immortalised cell culture
Primary hCEC culture from peripheral DMwith endothelial cells
(female, 64 years old, cadaveric donor cornea) was initiated via
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scissors and placed into a T25 cell culture ﬂask. Cells were initially
maintained in 1 ml basal medium OptiMEM-I supplemented with
8% Fetal Bovine Serum (FBS), 1% L-Glutamine, 1% penicillin/strep-
tomycin (all from Invitrogen/ThermoFisher Scientiﬁc). Small
amount of medium was used in order to allow the pieces of the
peripheral DM to come in contact with the bottom surface of the
ﬂask and to promote cell outgrowth into the ﬂask. The culture
mediumwas not exchanged until primary cell outgrowth occurred,
usually 7e14 days after culture initiation. After that, the culture
medium was exchanged every 2nd day until the culture reached
conﬂuence. After reaching conﬂuence the primary culture was sub-
cultured using 0.05% trypsin/EDTA.
HCEC-12 cells, purchased from The Leibniz Institute DSMZ
(German Collection of Microorganisms and Cell Cultures; Deutsche
Sammlung von Mikroorganismen und Zellkulturen, Catalogue
number ACC 646), were cultured using F99 (mixture of Ham's F12
and Medium 199 (ThermoFisher Scientiﬁc) in 1:1 ratio) medium
supplemented with 10% FBS. The medium was changed every 2
days. The cells were seeded out at the density of 50 cells/mm2.
Conﬂuent cultures were split 1:2 to 1:4 every 4e5 days using 0.05%
trypsin/EDTA. All cell cultures were kept in a humidiﬁed Heracell™
incubator at 37 C, 5% CO2, 95e98%.
2.3. Immunoﬂuorescent staining and laser scanning confocal
microscopy of cells
HCEC-12 and primary hCECs were cultured in glass chamber
slides, coated with 0.1 mg/ml poly-D-lysine (PDL) (Sigma Aldrich),
at 5000 cells/cm2 density for 24 h prior to ﬁxing and processing
for immunocytochemistry. The cells were ﬁxed in 4% para-
formaldehyde for 10 min at room temperature and permeabilised
using blocking solution (10% normal goat serum (Invitrogen/
ThermoFisher Scientiﬁc) in PBS) supplemented with 0.1% v/v
Triton X-100 for 20 min at room temperature. Following permia-
bilisation, cells were incubated in blocking solution for one hour at
room temperature. Primary antibodies were added to the ﬁxed
cells in blocking solution overnight at 4 C, followed by the in-
cubation with appropriate secondary antibodies. The following
primary antibodies were used: rabbit anti-Prdm4 antibody, Abcam
(ab156867), rabbit anti-Prdm5 antibody, Abcam (ab79016) and
rabbit anti-Prdm5, Abcam antibody (ab84572), all at 1:500 dilu-
tion, and mouse monoclonal anti-alpha 1 Naþ/K þ - ATPase
antibody, Abcam (ab7671) at a 1:100 dilution. Secondary goat anti-
rabbit and anti-mouse antibodies conjugated to Alexa 488 or Alexa
568 (Invitrogen/ThermoFisher Scientiﬁc) were used at 1:1000
dilution together with Hoechst DNA stain prior to mounting
immunolabelled cells in DAKO mounting medium. Immunola-
belled cells were visualized using the Leica Microsystems CMS
confocal microscope.
2.4. Immunohistochemical labelling of human cornea
Cornea were ﬁxed in formalin and embedded in parafﬁn for
processing using LEICA Bond-III automated system with LEICA
Bond Polymer Reﬁne Detection kit (DS9800) according to the
manufacturer's instruction. Bond Polymer Reﬁne Detection kit is a
biotin-free, polymeric horseradish peroxidase (HRP)-linker anti-
body conjugate system for the detection of tissue-bound mouse
and rabbit IgG's. All sections were subjected to antigen heat
retrieval at 100 C for 20 min prior to staining procedure using
either Epitope retrieval solution 1 (pH 6.0) (AR9961) for anti-
Prdm4 antibodies or Epitope retrieval solution 2 (pH9.0) (AR9640)
for anti-Prdm5 antibodies. Both antibodies were used at 1:500
dilution. The staining programme used was as follows: 1) peroxideblock - 5min, 2) primary antibody was applied for 30 min, 3)
polymer HRP was added for 8 min, 4) mixed DAB was added for
10 min. Sections were counterstained with haematoxylin for 5 min
to visualise nuclei.
3. Results
3.1. Expression of Prdm genes in healthy human cornea and
endothelial cell/Descemet membrane complex
To begin our investigations we initially utilized cadaveric whole
human cornea to assess expression proﬁles of all human Prdm
genes. The corneas obtained were from deceased 64 year old fe-
male, 69 year old male and 87 year old male.
To this end, total RNA isolated from the cornea were reverse
transcribed and the expression of Prdm genes was assessed using
gene-speciﬁc primers. We detected expression of ﬁve PrdmmRNAs
out of a total of 17 primer combinations tested. Prdm 1, 4 and 5
were expressed at relatively high levels, while Prdm 2 and 10
showed moderate to low expression levels in total normal human
cornea (Fig. 1A). Interestingly, when endothelial cells/Descemet
membrane complex alone were used as a source of total RNA,
expression of Prdm 1 was not detectable and we also detected a
very weak expression of Prdm 11 in the sample (Fig. 1B). Taken
together, our observations suggest that normal human cornea
express Prdm 1, 2, 4, 5 and 10 as part of their normal transcrip-
tional proﬁle, while Descemet Membrane with corneal endothelial
cells (DM/CECs) express Prdm 2, 4, 5, 10 and very weakly 11
(summarized in Table 1).
3.2. Expression of Prdm genes in primary and immortalised hCECs
We characterised the expression proﬁles of Prdm genes in pri-
mary hCECs by performing RT-PCR as outlined in section 3.1. We
detected expression of Prdm 1, 2, 4, 5 and 10 in primary hCECs as
was the case for healthy normal cornea (Fig. 2A). However, we also
detected Prdm 8 expression in our primary hCEC culture, which was
not detectable in whole human corneas. Therefore, while the Prdm
gene expression proﬁle of primary hCECs is similar to that of the
normal human cornea, it is not identical to it (summarized in
Table 1).
We utilized the cell line, HCEC-12 and investigated the expres-
sion proﬁle of Prdm genes in these cells. Whilst all Prdm genes
which are expressed in normal human cornea and DM/CECs are
also found in HCEC-12 cell line, there are several additional tran-
scripts found in these cells (Fig. 2B). Thus, in addition to Prdm 1, 2, 4,
5 and 10, we also detected expression of the following Prdm genes
in HCEC-12 cells: Prdm 3 (MECOM isoform), Prdm 6, 8, 11 and 16
(summarized in Table 1). Taken together, these observations sug-
gest that HCEC-12 cell line has a distinctly different transcriptional
proﬁle from healthy human corneas.
3.3. Expression of Prdm 4 and Prdm 5 proteins in HCEC-12 cell line
and primary hCECs
Given the importance of Prdm5 and 4 in corneal biology (Burkitt
Wright et al., 2011; Aldahmesh et al., 2012; Porter et al., 2015a;
Micheal et al., 2016a; Micheal et al. 2016b) and (MRC Harwell
web reference), we next focused our attention on the expression
of these two proteins in cultured hCECs. Immunostaining of HCEC-
12 cells to detect Prdm 4 expression revealed that Prdm 4 is found
both in the cytosol and the nucleus of HCEC-12 cells (Fig. 3A).
Moreover, Prdm 4 expressing HCEC-12 cells also expressed a well-
known marker of corneal endothelial cells, the Naþ/Kþ-ATPase
(Fig. 3B). We then investigated Prdm 4 protein expression in
Fig. 1. Expression of Prdm genes mRNAs in intact cornea and Descemet membrane/
corneal endothelial cells. A) Prdm gene mRNA assessed by RT-PCR with gene speciﬁc
primers in intact cornea and, B) in the DM/CECs. Prdm 1 expression is lost in the DM/
CECs and a very weak Prdm 11 expression becomes detectable.
Fig. 2. Expression of Prdm genes mRNAs in primary hCECs and immortalised HCEC-
12 cell line. A) Prdm genes expressed in primary hCECs harvested after two passages of
the culture and, B) Prdm genes expressed in primary HCEC-12 cell line harvested after
six passages of the culture. Note that expression proﬁle of Prdm genes is much closer to
the one observed in intact cornea in primary hCECs than in HCEC-12 immortalised
cells.
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together with the corneal endothelial cell marker, Naþ/Kþ-ATPase
(Fig. 3C). We found that Prdm 4 is expressed at relatively high levels
in these cells and localizes to the cytosol and to a lesser extent to the
nucleus of primary hCECs (Fig. 3C).Table 1
Summary of Prdm gene expression in normal cornea, DM/CECs and primary and imm


















Prdm16Immunostaining for HCEC-12 cells and primary hCECs with
antibodies against Prdm 5, revealed that the protein is expressed in
both cell types (Fig. 4A and B). Similar to Prdm 4, Prdm 5 was found
in both the cytosolic and the nuclear compartments of the cells andortalised CECs. þ denotes expression of mRNA for the respective gene; þ/ denotes











Fig. 3. Prdm 4 protein is expressed in HCEC-12 cells and primary hCECs. A) Fluorescent immunolabelling of HCEC-12 cells reveals that Prdm 4 protein (green) is localised to the
nucleus and the cytosol of immortalised HCEC-12 cells. B) HCEC-12 cells expressing Prdm 4 proteins also express CEC marker, Naþ/Kþ-ATPase (red), which is localised predomi-
nantly to the membrane of the cells. C) Prdm 4 protein (green) is expressed in primary hCECs (phCEC) together with the Naþ/Kþ-ATPase (red). Note that Prdm 4 protein is mainly
detected in the cytosol in these cells with the Naþ/Kþ-ATPase being conﬁned to the membrane predominantly. Nuclei are counterstained with Hoechst (blue). (For interpretation of
the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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conclude, that both, Prdm 4 and Prdm 5 proteins are expressed in
primary human corneal endothelial cells as well as the immortal-
ised HCEC-12 cells together with Naþ/Kþ-ATPase. Moreover, both
proteins can be detected in the nucleus and the cytosolic com-
partments of the cells suggesting that they function in both and
that their transport/accumulation in these two compartments may
be regulated.3.4. Expression of Prdm 4 and Prdm 5 proteins in human corneal
epithelium, stromal keratocytes and endothelium
To assess the tissue distribution of Prdm 4 and Prdm 5, we
investigated the distribution of both proteins in intact human
corneas. Both proteins were found in the endothelial cells of the
cornea as well as the epithelial cell layer and stromal keratocytes
(Figs. 5 and 6). Prdm 4 was found evenly distributed between both
the cytosolic and the nuclear compartments of the endothelial and
epithelial cells, somewhat enriched in perinuclear areas (just
outside the nucleus) (Fig. 5 A, B and C), contrasting with the pre-
dominantly cell membrane-speciﬁc immunoreactivity observed forthe endothelial cell marker, Naþ/Kþ-ATPase (Fig. 5D). Interestingly,
it appeared to localise to the nuclei of the stromal cells. Prdm 5
showed a much stronger immunoreactivity in both the endothelial
and the epithelial cells compared to the levels detected for Prdm 4
(Fig. 6 A, B and C). Moreover, while Prdm 5 was also found in both
cytosolic and nuclear compartments of these cells, it appeared
much more concentrated in the nucleus than Prdm 4. Furthermore,
no specialised enrichment of Prdm 5 in the perinuclear areas was
observed. Within the stromal keratocytes, Prdm 5 also appeared
localised to the nucleus and exhibited much weaker staining than
in either the epithelial or endothelial cells. The observed patterns of
subcellular distribution of both Prdm 4 and Prdm 5 suggest that the
functions these proteins have in corneal cells may be distinct.4. Discussion
Corneal endothelial cells are a unique population of cells which
function to preserve corneal clarity. CECs are generally known to be
post mitotic in their cell cycle with poor proliferative capacity
in vivo and in vitro. This offers signiﬁcant limitations to generate
CEC cultures in vitro for cell therapy, but nevertheless shown to be
Fig. 4. Prdm 5 protein is expressed in HCEC-12 cells and primary hCECs. A) Fluorescent immunolabelling of HCEC-12 cells reveals that Prdm 5 protein (green) is localised to the
nucleus and the cytosol of immortalised HCEC-12 cells. B) Prdm 5 protein (green) is expressed in primary hCECs (phCEC) together with the Naþ/Kþ-ATPase (red). Nuclei are
counterstained with Hoechst (blue). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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we focussed on the identiﬁcation of the Prdm genes, expressed in
the cornea and, speciﬁcally, in corneal endothelial cells, with a
long-term view to begin understanding their roles in CEC differ-
entiation and biology. Prdm family of transcriptional and epigenetic
regulators control differentiation and re-programming of a wide
variety of cell lineages (Fog et al., 2012; Hohenauer and Moore,
2012; Zannino and Sagerstr€om, 2015; Chi and Cohen, 2016) and
we reasoned that they may also play a role in controlling prolifer-
ation and differentiation of CECs.
In the ﬁrst instance we isolated total RNA from whole human
corneas and performed RT-PCR to investigate the expression proﬁle
of all Prdm genes. We identiﬁed Prdm 1, 2, 4, 5 and 10 in the intact
healthy corneas. We then investigated the expression patterns of
Prdm 4 and 5 proteins in more detail, as these two proteins have
been implicated in the control of corneal function, and discuss
them further in the context of their relevance to the CEC biology.
Prdm 4 was originally identiﬁed in a screen for low afﬁnity
neurotrophin receptor, p75NTR, interacting proteins (Chittka and
Chao, 1999) and has been shown to function as a transcriptional
regulator which recruits chromatin modifying enzymes, such as
histone deacetylases (HDACs) (Chittka et al., 2004) and a protein
arginine methyltransferase 5 (PRMT5) (Chittka et al., 2012) to
control gene expression. Prdm 4 is broadly expressed in many tis-
sues suggesting an important role for this protein in the control
of cellular differentiation and “stemness”, in part through
neurotrophin-mediated signalling. This is especially relevant given
that both p75NTR and another Nerve Growth Factor receptor, TrkA,
have been shown to be expressed in limbal basal epithelial cells of
the cornea, the primary site of the limbal stem cells (Qi et al., 2008)
and p75NTR is found in the human corneal endothelial progenitor
cells where it has been used to isolate and culture potential hCE
progenitor cells successfully (Hara Susumu et al., 2014). Intrigu-
ingly, mice with a homozygous deletion of Prdm 4 gene display
gender-speciﬁc abnormal corneal morphology suggesting thatPrdm 4, perhaps downstream of the p75NTR signalling, may be one
of the critical determinants of corneal biology (MRC Harwell web
reference). In this respect, it is noteworthy that we detected Prdm
4 protein expression both in the epithelial and the endothelial cells
of the cornea. Furthermore, our previous observations that Prdm 4
maintains the “stemness” of cortical neural stem cells during their
development (Chittka et al., 2012) suggest it may be important for
mediating a similar control of developmental fates of hCECs. Taken
together, our observations that Prdm 4 is expressed in the corneal
endothelial cells, that it was initially isolated as p75NTR interacting
protein and that the mice where Prdm 4 gene is deleted display
abnormalities in corneal morphology, strongly implicate Prdm 4 in
critical control of corneal endothelial cell differentiation.
Prdm 5 protein has been implicated in corneal biology as mu-
tations in Prdm 5 are associated with the BCS and other corneal
abnormalities (Burkitt Wright et al., 2011; Aldahmesh et al., 2012;
Porter et al., 2015a, 2015b; Micheal et al., 2016a; Micheal et al.
2016b). In part, Prdm 5 controls corneal integrity by regulating
expression of extracellular matrix components, such as ﬁbrillar
collagens, and loss of Prdm 5 function leads to corneal fragility and
rupture often resulting in blindness (Burkitt Wright et al., 2011).
Our ﬁnding of Prdm 5 expression in both corneal epithelial and
endothelial cells is an interesting addition to this reported
association.
Prdm 1 has a well characterised function in the control of pri-
mordial germ cell lineage (Ohinata et al., 2005; Günesdogan et al.,
2014) and B-cell lineage (Savitsky et al., 2007) as well as multiple
other cell lineages (Fog et al., 2012; Hohenauer and Moore, 2012),
but no information is available about its potential role in corneal
development. Prdm 2, also known as RIZ1 (Retinoblastoma-inter-
acting zinc-ﬁnger protein 1), is a tumour suppressor which exhibits
histone H3 lysine 9methyltransferase activity (Derunes et al., 2005)
and has been shown to be inactivated in a variety of tumours (Liu
et al., 2013; Tan et al., 2014; Zhang et al., 2015). Similar to Prdm 1,
no information is available about Prdm 2 function in the cornea.
Fig. 5. Prdm 4 protein is expressed in the intact cornea. A) Immunolabelling of the
intact cornea showing an overview of Prdm 4 protein distribution within the tissue.
Prdm 4 (brown staining) is found in the epithelial cells, endothelial cells and kerati-
nocytes of the stroma. B) and C) Higher magniﬁcation of the images demonstrating
Prdm 4 expression in the endothelial (B) and epithelial (C) cells of the cornea. Prdm 4
immunoreactivity is detected in the cytosol, concentrated at the perinuclear regions
and weakly in the nucleus of these cells. D) Endothelial cells of the cornea are
immunolabelled with antibodies against the Naþ/Kþ-ATPase (brown staining), which is
found at the membranes of these cells. Tissue sections are counterstained with hae-
matoxylin to visualise nuclei (blue) in all panels. (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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central nervous system and may be involved in the pathogenesis of
neuronal storage diseases which lead to mental retardation and
early childhood death (Siegel et al., 2002). Similar to Prdm 1 and 2,
there is currently no information available about its function in the
cornea.
In our analysis of Prdm genes expressed in the Descemet
membrane/corneal endothelial cells, we noticed that Prdm 1mRNA
was no longer detectable suggesting that Prdm 1 expression may
not be speciﬁc to the corneal endothelial cells. We also detected a
very weak Prdm 11 expression in this sample.We do not know if the
expression of Prdm 11 is induced by the preparation of the DM/CECs
or whether the isolated tissuemay have been slightly contaminated
with cells of other origin. It is noteworthy in this respect that Prdm
11 mRNA is also detectable in immortalised HCECs, perhaps indi-
cating alterations in expression proﬁles of Prdm genes following
ex vivo culture and immortalization. Similar to Prdm 1, 2 and 10, no
information is available on the potential function of Prdm 11 in the
cornea.
In assessing expression of Prdm genes in two cellular systems,
primary hCECs established from DM/CECs and in an immortalised
cell line, HCEC-12, we discovered that there were some differences
in the expression proﬁles of Prdm genes between DM/CECs isolated
from the cornea and both of the above cell lines. The most notable
difference between the DM/CEC tissue and the established hCECs
was expression of Prdm 8 in the latter cells. Prdm 8 is known to be
expressed in the developing mouse retina (Komai et al., 2009) and
is important in controlling rod bipolar and type 2 OFF-cone bipolar
cell survival as well as amacrine subtype identity (Jung et al., 2015),
implicating it in the regulation of speciﬁc aspects of eye develop-
ment and differentiation of speciﬁc cell types within the visual
system. However, Prdm 8 has not been implicated in the control of
corneal function and it is unclear whether primary hCECs we
established express it because of culture conditions or perhaps
some form of re-programming which may occur during longer-
term culturing of cells.
Immortalised HCEC-12 cells showed marked differences in the
expression proﬁle of detectable Prdm genes compared to those
expressed in DM/CECs isolated from intact cornea. In particular,
Prdm 3 (MECOM isoform), 6, 8 and 16 were detected in HCEC-
12 cells by RT-PCR in addition to those observed in DM/CECs tissue
preparations. Given that HCEC-12 cells are immortalised using the
early region of SV40 genome containing the large T antigen and the
small t-antigen, theymay be re-programmed to express other Prdm
genes as part of their phenotype. For example, Prdm 3 (Mecom
form) has a well-documented role in myeloid leukemogenesis
(Juneja et al., 2014) where it appears to control haematopoietic
stem cell (HSC) quiescence and survival of primary human
leukaemia cells; in this context Prdm 3 is part of the core “stem cell”
gene cluster shared by both HSCs and leukaemia stem cells (Eppert
et al., 2011). Conceivably, its expression in immortalised HCEC-
12 cells reﬂects their new cellular identity which may upregulate
some of the “stem cell” gene cluster genes to enhance the survival
of these cells. Prdm 6 has been shown to inhibit endothelial cell
proliferation, survival and differentiation (Wu et al., 2008) and its
expression in the HCEC-12 may be induced as part of the re-
programming of these cells. Prdm 16 is an important regulator of
adipose tissue as well as haematopoietic and cardiac tissue (Seale
et al., 2007; Kajimura et al., 2009; Arndt et al., 2013; Chi and
Cohen, 2016). Further, Prdm 16 has been shown to regulate
oxidative stress in both haematopoietic and neural stem cells (Chi
and Cohen, 2016) and some of the known chromosomal rear-
rangements involving Prdm 16 in humans lead to haematological
malignancies (Chi and Cohen, 2016). Therefore, Prdm 16 may also
contribute to the re-programmed phenotype of HCEC-12 cells aftertheir immortalization. Of note, Prdm 1, 2, 3 and 16 genes encode two
isoforms, those which contain the PR/SET domain and those which
lack it, and the biological roles of these two isoforms in controlling
cellular proliferation are opposite, with the PR/SET-containing
isoforms being anti-proliferative and the PR/SET-lacking isoforms
supporting cellular proliferation in a variety of cells (Di Zazzo et al.,
2013). Therefore, it will be important to investigate the distribution
of different isoforms of detected Prdm genes in various cell lines as
well as in normal cornea and primary hCECs in the future in order
Fig. 6. Prdm 5 protein is expressed in the intact cornea. A) Immunolabelling of the intact cornea showing an overview of Prdm 5 protein distribution within the tissue. Prdm 5
(brown staining) is found in the epithelial cells, endothelial cells and keratinocytes of the stroma. B) and C) Higher magniﬁcation of the images demonstrating Prdm 5 expression in
the epithelial (B) and endothelial (C) cells of the cornea. Prdm 5 exhibits strong immunoreactivity in the nuclei of both cell types and diffuse distribution within the cytosol of the
cells. Tissue sections are counterstained with haematoxylin to visualise nuclei (blue) in all panels. (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
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and differentiation.
In this report we focussed our attention on the characterisa-
tion of expression of Prdm genes in human cornea with the
special emphasis on the corneal endothelial cells with the view
of identifying those Prdm genes which may be important for CEC
biology. Of the Prdm genes identiﬁed in our screen, we further
analysed expression of Prdm 4 and 5 proteins in intact corneas as
well as primary hCECs and HCEC-12 cell line. We found that
Prdm 4 and 5 are expressed in both corneal endothelial and
epithelial cells with slightly different subcellular distribution of
these two proteins within the above cells. The remaining Prdm
genes identiﬁed in this screen will warrant further study to un-
derstand their contribution to the biology of CECs. We focussed
on Prdm 4 and 5 genes in part because there is evidence which
implicates both of these proteins in corneal biology. The role of
Prdm 5 is by far better understood, while Prdm 4 is clearly a
novel candidate with potentially important roles in corneal
biology. Indeed, it is especially intriguing, given that Prdm 4 wasinitially cloned in a screen for p75NTR interacting proteins
(Chittka and Chao, 1999), as p75NTR has been used successfully
to enrich for corneal endothelial precursor cells (Hara Susumu
et al., 2014). It will be important in the future to investigate
the precise role of Prdm 4 in corneal biology and the biology of
corneal endothelial cells with a view of potentially using it as a
marker in conjunction with p75NTR.5. Conclusions
We present evidence that Prdm 2, 4, 5 and 10 genes are
expressed in hCECs and in the whole human cornea. Moreover,
Prdm 4 and 5 proteins are found in the CECs of the cornea where
they are distributed both in the nucleus and the cytosol. Identiﬁ-
cation of these in part novel genes, which are important in con-
trolling cellular proliferation and differentiation, adds to the
repertoire of potentially important players in helping the genera-
tion of CECs for therapeutic purposes in future studies.
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